CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 30 enrolled
Drug / intervention
RevitaLens OcuTec MPS (Investigational MPS) and Opti-Free RepleniSH MPS (control)device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01024855
NCT01024855Phase 2Completed
CompareCT.gov

Comparative Evaluation of Corneal Staining With Balafilcon A Lenses and Two Multi-Purpose Solutions

Abbott Medical Optics·interventional·Posted Dec 3, 2009·Updated Oct 20, 2015

In Brief

A Phase 2 clinical trial evaluating RevitaLens OcuTec MPS (Investigational MPS) and Opti-Free RepleniSH MPS (control) for Myopia and 2 related conditions. Completed, enrolled 30 participants across 1 site.

Detailed Summary

A new multi-purpose solution (MPS)was clinically evaluated against Opti-Free RepleniSH MPS at specific time points over the course of four days. The study was conducted with PureVision lenses.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMyopia, Hyperopia, Astigmatism
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedDec 3, 2009
Enrollment StartApr 1, 2009
Primary CompletionJun 1, 2009
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 16.6 years ago

Interventions

RevitaLens OcuTec MPS (Investigational MPS) and Opti-Free RepleniSH MPS (control)device

multi-purpose lens care solution